Press release
Global Cerebrospinal Fluid (CSF) Management Market to Reach USD 5.39 Billion by 2031, Driven by Neurosurgical Advancements and Increasing Hydrocephalus Cases
Request Sample: https://clearviewmarketinsights.com/report-details/global-cerebrospinal-fluid-management-market/
"Modern CSF management solutions are transforming the treatment landscape for hydrocephalus, traumatic brain injury, and intracranial hypertension," said Dr. Sophia Lindgren, neurodevices analyst at CVMI.
Key Market Highlights
• 2024 Market Size: USD 2.43 billion
• 2031 Forecast: USD 5.39 billion
• CAGR: 12.1% (2024-2031)
Growth Catalysts
• Surge in hydrocephalus cases: especially in aging and pediatric populations.
• Trauma and TBI Increase: Surging demand for ICP management devices.
• Technological Innovations: Programmable, antimicrobial, and AI-enabled shunt systems.
Segment Insights
• Top Product: Shunt systems hold over 65% market share.
• Fastest-Growing Segment: External drainage systems for critical care and ICP management.
• Regional leaders: North America leads, with Europe in second; Asia-Pacific is the fastest-growing.
Competitive Overview (2024)
• Medtronic - 27%: Leading with advanced programmable shunts.
• Integra - 22%: Strong portfolio in drainage systems and valves.
• B. Braun - 16%: Focused on high-performance CSF drainage.
• Others - 35%: Mix of regional players and specialized OEMs.
Outlook to 2031
The CSF management market will grow with innovations in wireless ICP monitoring, antimicrobial coatings, and AI-powered decision support. Expansion in emerging markets, along with improvements in neurosurgical care, will drive future growth.
For detailed insights or media inquiries, contact:
Clearview Market Insights - Neurological Devices Division
Bhavani K
ClearView Market Insights
Mail: sales@clearviewmarketinsights.com
Phone: +1 917-993-7369
About Clearview Market Insights:
Clearview Market Insights is a leading market research and consulting firm providing in-depth industry analysis and strategic recommendations for businesses worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Cerebrospinal Fluid (CSF) Management Market to Reach USD 5.39 Billion by 2031, Driven by Neurosurgical Advancements and Increasing Hydrocephalus Cases here
News-ID: 4253651 • Views: …
More Releases from ClearView Market Insights
Global Chromatography Syringe Market to Reach USD 1.96 Billion by 2031, Driven b …
[Chicago, 08 October 2025] - Clearview Market Insights (CVMI) predicts that the global chromatography syringe market will increase from USD 1.03 billion in 2024 to USD 1.96 billion by 2031, with a CAGR of 9.5%. The rising demand is due to growing pharmaceutical research, food safety testing, and environmental monitoring.
"Chromatography syringes are the backbone of precise analytical testing, ensuring accuracy and reliability in industries where quality matters most," said…
Global Chromatography Market to Exceed USD 30.2 Billion by 2031, Driven by Pharm …
[London, 06 October 2025] - Clearview Market Insights (CVMI) reports that the global chromatography market will grow from USD 14.85 billion in 2024 to USD 30.21 billion by 2031, at a CAGR of 10.4%. Increasing demand for analytical testing in pharmaceuticals, biotechnology, and environmental safety is driving market expansion.
"Chromatography has become an essential tool for ensuring product quality, safety, and compliance across various industries," said Dr. Rachel Bennett, senior…
Global Chordal Suture System Market to Surpass USD 1.06 Billion by 2031, Driven …
[Boston, 06 October 2025] - Clearview Market Insights (CVMI) projects that the global chordal suture system market will grow from USD 470 million in 2024 to USD 1.06 billion by 2031, registering a CAGR of 12.1%. This growth is driven by increasing adoption of minimally invasive mitral valve repair techniques and expanding treatment options for structural heart disease.
"Chordal suture systems are transforming the landscape of mitral valve repair by…
Global Chondroitin Sulfate Market to Exceed USD 3.4 Billion by 2031, Fueled by N …
[New York, 06 September 2025] - Clearview Market Insights (CVMI) predicts that the global chondroitin sulfate market will rise from USD 1.68 billion in 2024 to USD 3.41 billion by 2031, with a CAGR of 10.6%. Growing osteoarthritis cases, increased adoption of preventive healthcare, and expanding cosmetic uses drive the growth.
Request Sample: https://clearviewmarketinsights.com/report-details/global-chondroitin-sulfate-market/
"Chondroitin sulfate's versatility in pharmaceuticals, supplements, and cosmetics is positioning it as a high-demand bioactive ingredient worldwide,"…
More Releases for CSF
G Csf And G Csf Biosimilars Market Size Trends and Forecast by Application, Type …
USA, New Jersey- According to Market Research Intellect, the global G Csf And G Csf Biosimilars market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period.
The G-CSF and G-CSF biosimilars market is witnessing steady growth, largely due to increasing demand for affordable treatments for neutropenia, especially…
G-CSF & G-CSF Biosimilars Market Growth 2032: Increasing Cancer Treatment Demand …
The global market for Granulocyte Colony Stimulating Factor (G-CSF) and G-CSF biosimilars is on a promising growth trajectory as the demand for cost-effective and therapeutic alternatives to branded drugs increases. G-CSF and its biosimilars are vital in treating neutropenia, leukopenia, platelet disorders, and various types of cancer, and their growing adoption is fueled by technological advancements and supportive government policies.
The market size was valued at $5.89 billion USD in 2023…
G-CSF and G-CSF Biosimilars Market Size, Growth and Forecast 2021 to 2028 By Ame …
The worldwide G-CSF and G-CSF Biosimilars market report is the very much investigated answer for the chiefs and academicians who are looking for a definite examination regarding both subjective just as quantitative, for the notable time frame and for the impending years gauge. The exploration report includes the business outline alongside the approaching dangers and supporting components that will drive or hamper the market development and give open doors sooner…
G-CSF and G-CSF Biosimilars Market Size to Witness Huge Growth by 2027: Pfizer, …
G-CSF and G-CSF Biosimilars market Research Report
LOS ANGELES, United States: QY Research offers an overarching research and analysis-based study on, “Global G-CSF and G-CSF Biosimilars Market Report, History and Forecast 2016-2027, Breakdown Data by Manufacturers, Key Regions, Types and Application“. This report offers an insightful take on the drivers and restraints present in the market. G-CSF and G-CSF Biosimilars data reports also provide a 5 year pre-historic and forecast…
Global G-CSF And G-CSF Biosimilars Market 2025| By Top Key Players Pfizer, Novar …
G-CSF, which is also known as filgrastim, is a growth factor used to aid the recovery of bone marrow after chemotherapy treatment for cancer, especially in patients with neutropenia (low white blood cell count in the blood), which causes reduced resistance to infections. It can also be used to stimulate mobilization of haematopoietic stem cells for collection and transplantation.
Request Sample Copy of Report @ https://www.researchtrades.com/request-sample/1664081
This report studies…
China CSF Management Market Outlook to 2023
New report, "China CSF Management Market Outlook to 2023", provides key market data on theChina CSF Management market. The report provides value, in millions of US dollars, volume (in units) and and average prices (USD) within market segments - Hydrocephalus Shunts and Dura Substitutes.
The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on…
